Stephen Szára

From Wikipedia, the free encyclopedia

Stephen Szára (b. 1923) is a Hungarian chemist and psychologist who has made major contributions in the field of pharmacology.[1]

The psychotropic effects of N.N-Dimethyltryptamine (DMT) were first studied scientifically by the Dr. Stephen Szára who performed research with volunteers in the mid-1950s. Szára, who later worked for the U.S. National Institutes of Health, had turned his attention to DMT after his order for LSD from the Swiss company Sandoz Laboratories was rejected on the grounds that the powerful psychotropic could be dangerous in the hands of a communist country.

In 1970, at the annual meeting of the AAAS, Dr. Szara presented the biochemistry of the first three psychedelic cogeners of tryptamine: dimethyl-, diethyl-, and dipropyl-tryptamine (DMT,DET, and DPT). He also showed that the half lives of their psychological effects in normal humans are about 5 minutes, 30 minutes, and 2 hours, respectively. DMT and DET can be snorted or smoked, giving extremely rapid onsets of psychedelic states. DPT has a slower onset and its psychological effect is much less pronounced than those of the other two.



[edit] References

  1. ^ Simon, Andrew L (1998). Made in Hungary: Hungarian Contributions to Universal Culture. Safety Harbor, FL: Simon Publishing, pp. 344-345. OCLC: 41712910. ISBN 9780966573428. 


Hungary  This Hungarian biographical article is a stub. You can help Wikipedia by expanding it.
This biographical article about a chemist is a stub. You can help Wikipedia by expanding it.